Systematic meta-analysis identifies distinct molecular subgroups of thymic epithelial tumors, suggesting diverse treatment paths.
Introduction Thymic epithelial tumors are rare cancers of the anterior mediastinum with heterogeneous clinical behaviors. Despite numerous attempts to characterize their mutational landscape, a comprehensive understanding of their genetic alterations remains limited due to small sample sizes. Methods To address this gap, we conducted a systematic meta-analysis of somatic mutations reported in 729 patients across twenty studies, integrating single-variant data into a unified dataset. Results This approach identified three molecular subgroups with distinct biological and clinical features. Tumors harboring GTF2I mutations were typically indolent, exhibited low mutational burden, and showed enrichment in pathways related to cell adhesion. Tumors with TP53 mutations displayed high mutational load, activation of receptor tyrosine kinase and mitogenic signaling, and corresponded to aggressive clinical behavior. Tumors lacking both GTF2I and TP53 mutations revealed intermediate pro les, characterized by alterations in epigenetic regulation and extracellular matrix organization. Mutational signature analysis indicated that age-related processes predominate in less aggressive tumors, while DNA repair de ciency characterizes those with TP53 mutations. Network and pathway analyses revealed convergent oncogenic hubs and distinct signaling dependencies across subgroups. Discussion This large-scale integrative study provides a re ned map of the genetic landscape of thymic epithelial tumors, highlights biologically meaningful heterogeneity, and establishes a framework to guide future research and the development of targeted therapies.
No takes yet. Share an insight, caveat, or question.
Pardini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: